Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

Women leaders are driving success in life sciences but remain underrepresented and undervalued. That needs to change, writes ...

Pay close attention to contract language regarding royalties, including when and where patents expire, or pay the price, ...

Believing “good companies are bought, not sold” does not reflect the reality of most life sciences transactions, write ...

Part one of a two-part series on FDA Commissioner Martin Makary, M.D.s comments at the Gailen Forum in New York City on October 30, 2025.

Since the start of his second term, President Trump has shown a clear commitment to improving access to medicines for American patients. In late September 2025, his Administration reaffirmed this ...

During a July episode of the Business of Biotech, Ebrahim Delpassand, M.D., founder, chairman, and CEO at RadioMedix, pointed out the importance of knowing, as a company, what you do best. It won’t be ...

This whitepaper provides a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.

My daughter Vicky is 11 years old, and she is going blind. She has RDH12-associated Leber congenital amaurosis (RDH12-LCA), a rare genetic eye disease that causes progressive loss of vision in ...

In a candid discussion with members of the media last month, Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) — the organization that birthed Lykos Therapeutics ...

Clinical trial participation is fundamental to medical progress, yet improving enrolment across diverse populations remains a persistent challenge. Early phase clinical trials — particularly Phase 1 ...

Biopharma leaders are often celebrated for the breakthroughs their companies pursue, from the elegant science to the pioneering modalities and the once-impossible therapies edging closer to reality.